DIAFER

This brand name is authorized in Austria, Estonia, Ireland, Lithuania, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug DIAFER contains one active pharmaceutical ingredient (API):

1 Iron (III) isomaltose complex UNII AHU547PI9H - FERRIC DERISOMALTOSE

Ferric derisomaltose is a complex of iron (III) hydroxide and derisomaltose, an iron carbohydrate oligosaccharide that releases iron. Iron binds to transferrin for transport to erythroid precursor cells to be incorporated into hemoglobin. It is used for the treatment of iron deficiency anemia (IDA) in adult patients.

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DIAFER Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1624698, 1624700, 1624711, 1624722
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 234131
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1071183, 1072969, 1072970, 1072971
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 119830
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100300383
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W60660001, W60660002, W60660003, W60660004